AbbVie (ABBV) Interest Coverage Ratio (2012 - 2016)
AbbVie (ABBV) reported Interest Coverage Ratio of 0.37 for Q2 2016, down 118.75% year-over-year from 1.96 in Q3 2015, and down 103.47% on a QoQ basis from 10.6 in Q1 2016.
AbbVie (ABBV) has 5 years of Interest Coverage Ratio data on file, last reported at 0.37 in Q2 2016.
- Quarterly Interest Coverage Ratio fell 118.75% year-over-year to 0.37 in Q2 2016, while the trailing twelve-month figure through Mar 2017 was 28.54 (up 246.11% YoY) and the FY2015 annual result came in at 10.48, up 31.84% from the prior year.
- Interest Coverage Ratio declined to 0.37 in Q2 2016 per ABBV's latest filing, from 10.6 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 159.6 in Q3 2012 and bottomed at 2.99 in Q4 2014.
- The 5-year median for Interest Coverage Ratio is 15.45 (2013), against an average of 21.39.
- The widest annual swing landed in 2015, when Interest Coverage Ratio soared 440.25%; it then tumbled 118.75% in 2016.
- Tracing ABBV's Interest Coverage Ratio over 5 years: stood at 19.37 in 2012, then increased by 7.08% to 20.74 in 2013, then slumped by 114.39% to 2.99 in 2014, then soared by 440.25% to 10.16 in 2015, then sank by 103.62% to 0.37 in 2016.
- Per Business Quant, the three latest ABBV Interest Coverage Ratio figures stand at 0.37 (Q2 2016), 10.6 (Q1 2016), and 10.16 (Q4 2015).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 23.39 |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | - |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | - |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 4.06 |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 10.78 |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | - |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2016 | -0.37 |
| Mar 31, 2016 | 10.60 |
| Dec 31, 2015 | 10.16 |
| Sep 30, 2015 | 9.11 |
| Jun 30, 2015 | 1.96 |
| Mar 31, 2015 | 12.78 |
| Dec 31, 2014 | -2.99 |
| Sep 30, 2014 | 6.49 |
| Jun 30, 2014 | 20.75 |
| Mar 31, 2014 | 19.30 |
| Dec 31, 2013 | 20.74 |
| Sep 30, 2013 | 18.28 |
| Jun 30, 2013 | 18.39 |
| Mar 31, 2013 | 18.13 |
| Dec 31, 2012 | 19.37 |
| Sep 30, 2012 | 159.60 |